Academic article

• Chyou, Janice Y.; Tay, Wan Ting; Tromp, Jasper et al. (2025). Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure. (external link)
• Tay, Wan Ting; Teng, Tiew-Hwa Katherine; Ouwerkerk, Wouter et al. (2025). Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry. (external link)
• Cao, Thong Huy; Tay, Wan Ting; Jones, Donald J.L. et al. (2024). Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry. (external link)
• Beverborg, Niels Grote; Alnuwaysir, Ridha I.S.; Markousis-Mavrogenis, George et al. (2024). The transcriptional profile of iron deficiency in patients with heart failure: Heme-sparing and reduced immune processes. (external link)
• Adamo, Marianna; Pagnesi, Matteo; Pasquale, Mattia Di et al. (2024). Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF. (external link)
• Bistola, Vasiliki; Farmakis, Dimitrios; Tromp, Jasper et al. (2024). Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction: A Global Perspective. (external link)
• Tokodi, Márton; Kosztin, Annamária; Kovács, Attila et al. (2024). Machine learning-based prediction of 1-year all-cause mortality in patients undergoing CRT implantation: validation of the SEMMELWEIS-CRT score in the European CRT Survey I dataset. (external link)
• Monzo, Luca; Bresso, Emmanuel; dickstein, kenneth et al. (2024). Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction. (external link)
• Normand, Camilla Jacqueline Hansine; Bogale, Nigussie; Linde, Cecilia et al. (2024). National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients. (external link)
• Mullens, Wilfried; Dauw, Jeroen; Gustafsson, Finn et al. (2024). Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). (external link)
• Gatti, Paolo; Linde, Cecilia; Benson, Lina et al. (2023). What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II. (external link)
• Tromp, Jasper; Ezekowitz, Justin A.; Ouwerkerk, Wouter et al. (2023). Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. (external link)
• Katsanos, Spyridon; Ouwerkerk, Wouter; Farmakis, Dimitrios et al. (2023). Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry. (external link)
• Dewan, Pooja; Ferreira, João Pedro; Butt, Jawad H. et al. (2023). Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE. (external link)
• Streng, Koen W.; Hillege, Hans L.; Maaten, Jozine M. ter et al. (2023). Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction. (external link)
• Gerhardt, Teresa; Gerhardt, Louisa M S; Ouwerkerk, Wouter et al. (2023). Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. (external link)
• Baumhove, Lukas; Bomer, Nils; Tromp, Jasper et al. (2023). Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D. (external link)
• Koning, Marie-Sophie L. Y. de; Emmens, Johanna E.; Romero-Hernández, Esteban et al. (2023). Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure. (external link)
• Boorsma, Eva M.; Maaten, Jozine M. ter; Damman, Kevin et al. (2023). Albuminuria as a marker of systemic congestion in patients with heart failure. (external link)
• Hoef, Camilla C.S. van der; Boorsma, Eva M.; Emmens, Johanna E. et al. (2023). Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. (external link)
• Farmakis, Dimitrios; Tromp, Jasper; Marinaki, Smaragdi et al. (2023). Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. (external link)
• Ouwerkerk, Wouter; Pereira, Joao P. Belo; Maasland, Troy et al. (2023). Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. (external link)
• Weening, Eerde H.; Al-Mubarak, Ali A.; Dokter, Martin M. et al. (2023). Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease. (external link)
• Markousis-Mavrogenis, George; Minich, Waldemar B.; Al-Mubarak, Ali A. et al. (2023). Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. (external link)
• Wolsk, Emil; Claggett, Brian; Diaz, Rafael et al. (2022). Risk estimates of imminent cardiovascular death and heart failure hospitalization are improved using serial natriuretic peptide measurements in patients With coronary artery disease and type 2 diabetes. (external link)
• Pandhi, Paloma; Maaten, Jozine M. ter; Anker, Stefan D. et al. (2022). Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure. (external link)
• McNaughton, Candace D.; McConnachie, Alex; Cleland, John G. et al. (2022). Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure). (external link)
• Ceelen, Daan; Voors, Adriaan A.; Tromp, Jasper et al. (2022). Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure. (external link)
• Koçyiğit, Duygu; Sarıgül, Nedim Umutay; Altın, Timuçin et al. (2022). Upgrades from Previous Cardiac Implantable Electronic Devices Compared to De Novo Cardiac Resynchronization Therapy Implantations: Results from CRT Survey-II in the Turkish Population. (external link)
• Curtain, James P.; Campbell, Ross T.; Petrie, Mark C. et al. (2022). Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF. (external link)
• Tromp, Jasper; Ouwerkerk, Wouter; Teng, Tiew-Hwa K. et al. (2022). Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. (external link)
• Baumhove, Lukas; Tromp, Jasper; Figarska, Sylwia et al. (2022). Heart failure with normal LVEF in BIOSTAT-CHF. (external link)
• Pagnesi, Matteo; Adamo, Marianna; Sama, Iziah E. et al. (2022). Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure. (external link)
• Tromp, Jasper; Beusekamp, Joost C.; Ouwerkerk, Wouter et al. (2022). Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. (external link)
• Inciardi, Riccardo M.; Pagnesi, Matteo; Lombardi, Carlo M. et al. (2022). Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure. (external link)
• Cooper, Trond Johan; Cleland, John G.F.; Guazzi, Marco et al. (2022). Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial. (external link)
• Ravera, Alice; Santema, Bernadet T.; Boer, Rudolf A. de et al. (2022). Distinct pathophysiological pathways in women and men with heart failure. (external link)
• Santema, Bernadet T.; Arita, Vicente Artola; Sama, Iziah E. et al. (2022). Pathophysiological pathways in patients with heart failure and atrial fibrillation. (external link)
• Ouwerkerk, Wouter; Tromp, Jasper; Cleland, John G.F. et al. (2022). Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. (external link)
• Gerstein, Hertzel C.; Hess, Sibylle; Claggett, Brian et al. (2022). Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study. (external link)
• Hall, Trygve Sørdahl; Ørn, Stein; Zannad, Faiez et al. (2022). The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction. (external link)
• Bracun, Valentina; Essen, Bart van; Voors, Adriaan A. et al. (2022). Insulin-like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. (external link)
• Streng, Koen W.; Hillege, Hans L.; Maaten, Jozine M. ter et al. (2022). Clinical implications of low estimated protein intake in patients with heart failure. (external link)
• Kondo, Toru; Abdul-Rahim, Azmil H.; Talebi, Atefeh et al. (2022). Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. (external link)
• Savarese, Gianluigi; Uijl, Alicia; Ouwerkerk, Wouter et al. (2022). Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction. (external link)
• Emmens, Johanna E.; Borst, Martin H. de; Boorsma, Eva M. et al. (2022). Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure. (external link)
• Markousis-Mavrogenis, George; Tromp, Jasper; Ouwerkerk, Wouter et al. (2022). Multimarker profiling identifies protective and harmful immune processes in heart failure: Findings from BIOSTAT-CHF. (external link)
• Ferreira, João Pedro; Ouwerkerk, Wouter; Santema, Bernadet T et al. (2021). Differences in biomarkers and molecular pathways according to age for patients with HFrEF. (external link)
• Hui, Sonya K.; Sharma, Abhinav; Docherty, Kieran et al. (2021). Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: Insights from the high-risk myocardial infarction database. (external link)
• Boorsma, Eva M.; Maaten, Jozine M. ter; Damman, Kevin et al. (2021). Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure. (external link)
• Ravera, Alice; Santema, Bernadet T.; Sama, Iziah E. et al. (2021). Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire. (external link)
• Mullens, Wilfried; Auricchio, Angelo; Martens, Pieter et al. (2021). Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. (external link)
• Pandhi, Paloma; Streng, Koen W.; Anker, Stefan D. et al. (2021). The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. (external link)
• Woolley, Rebecca J.; Ceelen, Daan; Ouwerkerk, Wouter et al. (2021). Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. (external link)
• Pagnesi, Matteo; Adamo, Marianna; Sama, Iziah E. et al. (2021). Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. (external link)
• Kobayashi, Masatake; Voors, Adriaan A.; Ouwerkerk, Wouter et al. (2021). Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure. (external link)
• Curran, Fraser M.; Bhalraam, U.; Mohan, Mohapradeep et al. (2021). Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction. (external link)
• Tromp, Jasper; Ouwerkerk, Wouter; Cleland, John G. et al. (2021). Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF. (external link)
• Gupta, Pankaj; Voors, Adriaan A.; Patel, Prashanth et al. (2021). Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study). (external link)
• Khan, Muhammad Shahzeb; Kristensen, Søren L.; Vaduganathan, Muthiah et al. (2021). Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials. (external link)
• Shen, Li; Claggett, Brian; Jhund, Pardeep S. et al. (2021). Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE. (external link)
• Emmens, Johanna E.; Jia, Congzhuo; Ng, Leong L. et al. (2021). Impaired high-density lipoprotein function in patients with heart failure. (external link)
• Alnuwaysir, Ridha I.S.; Beverborg, Niels Grote; Hoes, Martijn F. et al. (2021). Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study. (external link)
• Al-Mubarak, Ali A.; Beverborg, Niels Grote; Anker, Stefan D. et al. (2020). A clinical tool to predict low serum selenium in patients with worsening heart failure. (external link)
• Sama, Iziah E.; Woolley, Rebecca J.; Nauta, Jan F. et al. (2020). A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure. (external link)
• Sus, Ioana; Vatasescu, Radu; Siliste, Calin et al. (2020). Cardiac resynchronization therapy in Romania – results from the european society of cardiology CRT survey II. (external link)
• Dewan, Pooja; Jackson, Alice; Jhund, Pardeep S. et al. (2020). The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. (external link)
• Filippatos, Gerasimos; Angermann, Christiane E.; Cleland, John G.F. et al. (2020). Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. (external link)
• Ranganathan, Deepti; Sharif, Zain; Murphy, Theodore et al. (2020). CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy—an Irish subset analysis. (external link)
• Lombardi, Carlo; Ferreira, João Pedro; Carubelli, Valentina et al. (2020). Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. (external link)
• Davison, Beth A.; Senger, Stefanie; Sama, Iziah E. et al. (2020). Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF. (external link)
• Shin, Sung-Hee; Claggett, Brian; Pfeffer, Marc A. et al. (2020). Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome. (external link)
• Rossignol, Patrick; Duarte, Kevin; Girerd, Nicolas et al. (2020). Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction. (external link)
• Docherty, Kieran F.; Ferreira, João Pedro; Sharma, Abhinav et al. (2020). Predictors of sudden cardiac death in high-risk patients following a myocardial infarction. (external link)
• Koçyiğit, Duygu; Sarigul, Nedim Umutay; Altın, Timuçin et al. (2020). Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II. (external link)
• Shi, C.; Wal, Haye H. van der; Dokter, Martin et al. (2020). Tumour biomarkers: association with heart failure outcomes. (external link)
• Ventina, Madarar; Kalçjs, Oskars; Vikmane, Maija et al. (2020). SECOND EUROPEAN CARDIAC RESYNCHRONISATIONTHERAPY SURVEY (CRT SURVEY II): LATVIAN DATACOMPARED TO EUROPE. (external link)
• Sama, Iziah E.; Ravera, Alice; Santema, Bernadet T. et al. (2020). Circulating plasma concentrations of angiotensin-converting enzyme 2 inmen and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. (external link)
• Botto, Giovanni Luca; Gasparini, Maurizio; Brasca, Francesco M.A. et al. (2020). Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohort. (external link)
• Tromp, Jasper; Bamadhaj, Sahiddah; Cleland, John G. et al. (2020). Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. (external link)
• Mullens, Wilfried; Auricchio, Angelo; Martens, Pieter et al. (2020). Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology. (external link)
• Tromp, Jasper; Voors, Adriaan A.; Sharma, Abhinav et al. (2020). Distinct Pathological Pathways in Patients With Heart Failure and Diabetes. (external link)
• Mordi, Ify R.; Ouwerkerk, Wouter; Anker, Stefan D. et al. (2020). Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. (external link)
• Kristensen, Søren Lund; Castagno, Davide; Shen, Li et al. (2020). Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE. (external link)
• Kloosterman, Mariëlle; Santema, Bernadet T.; Roselli, Carolina et al. (2020). Genetic risk and atrial fibrillation in patients with heart failure. (external link)
• Normand, Camilla Jacqueline Hansine; Linde, Cecilia; Blomström-Lundqvist, Carina et al. (2020). Adherence to ESC cardiac resynchronization therapy guidelines: Findings from the ESC CRT Survey II. (external link)
• Ouwerkerk, Wouter; Teng, Tiew-Hwa K.; Tromp, Jasper et al. (2020). Effects of combined renin–angiotensin–aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries. (external link)
• Maaten, Jozine M. ter; Martens, Pieter; Damman, Kevin et al. (2020). Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. (external link)
• Jaarsma, Tiny; Klompstra, Leonie; Ben-Gal, Turia et al. (2020). Effects of exergaming on exercise capacity in patients with heart failure: results of an international multicentre randomized controlled trial. (external link)
• Kobayashi, Masatake; Stienen, Susan; Maaten, Jozine M. ter et al. (2020). Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure. (external link)
• Simpson, Joanne; Jhund, Pardeep S.; Lund, Lars H. et al. (2020). Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure. (external link)
• Nielsen, Jens Cosedis; Kautzner, Josef; Casado-Arroyo, Ruben et al. (2020). Remote monitoring of cardiac implanted electronic devices: Legal requirements and ethical principles - ESC Regulatory Affairs Committee/EHRA joint task force report. (external link)
• Beverborg, Niels Grote; Wal, Haye H. van der; Klip, IJsbrand T. et al. (2019). Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients with Heart Failure: Results from the DEFINE-HF and BIOSTAT-CHF Studies. (external link)
• Markousis-Mavrogenis, George; Tromp, Jasper; Ouwerkerk, Wouter et al. (2019). The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. (external link)
• Maaten, Jozine M. ter; Kremer, Daan; Demissei, Biniyam G. et al. (2019). Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure. (external link)
• Dewan, Pooja; Rørth, Rasmus; Jhund, Pardeep S. et al. (2019). Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis. (external link)
• Stienen, Susan; Ferreira, João Pedro; Girerd, Nicolas et al. (2019). Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative. (external link)
• Steen, Torkel; Sciaraffia, Elena; Normand, Camilla Jaqueline Hansine et al. (2019). Contemporary practice of CRT implantation in scandinavia compared to Europe. (external link)
• Dewan, Pooja; Rørth, Rasmus; Jhund, Pardeep S. et al. (2019). Differential impact of heart failure with reduced ejection fraction on men and women. (external link)
• Santema, Bernadet T.; Ouwerkerk, Wouter; Tromp, Jasper et al. (2019). Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. (external link)
• Auricchio, Angelo; Gasparini, Maurizio; Linde, Cecilia et al. (2019). Sex-related procedural aspects and complications in CRT survey II: A multicenter European experience in 11,088 patients. (external link)
• Ferreira, João Pedro; Metra, Marco; Anker, Stefan D. et al. (2019). Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. (external link)
• Kobayashi, Masatake; Voors, Adriaan A.; Girerd, Nicolas et al. (2019). Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. (external link)
• Nauta, Jan F.; Hummel, Yoran M.; Tromp, Jasper et al. (2019). Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment. (external link)
• Gauthey, Anaïs; Willems, Rik; Vandekerckhove, Yves et al. (2019). Benchmarking Belgian CRT practice against the rest of Europe: insights from the ESC-CRT survey II. (external link)
• Tajstra, Mateusz; Łasocha, Damian; Gadula-Gacek, Elżbieta et al. (2019). Cardiac resynchronization in Poland – comparable procedural routines? Insights from CRT Survey II. (external link)
• Ferreira, João Pedro; Ouwerkerk, Wouter; Tromp, Jasper et al. (2019). Cardiovascular and non-cardiovascular death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF study. (external link)
• Lawin, Dennis; Israel, Carsten W.; Linde, Cecilia et al. (2019). Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II. (external link)
• Coiro, Stefano; Girerd, Nicolas; Sharma, Abhinav et al. (2019). Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure. (external link)
• Galand, Vincent; Linde, Cecilia; Lellouche, Nicolas et al. (2019). The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France. (external link)
• Rossello, Xavier; Ferreira, João Pedro; McMurray, John JV et al. (2019). Editor’s Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction. (external link)
• Łasocha, Damian; Sterliński, Maciej; Tajstra, Mateusz et al. (2019). Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II registry. (external link)
• Normand, Camilla Jaqueline Hansine; Linde, Cecilia; Bogale, Nigussie et al. (2019). Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II. (external link)
• Mordi, Ify R.; Santema, Bernadet T.; Kloosterman, Mariëlle et al. (2019). Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation. (external link)
• Papiashvili, G.; Machitidze, G.; Linde, C. et al. (2019). EUROPEAN CARDIAC RESYNCHRONIZATION THERAPY SURVEY II: COMPARISON OF RESULTS IN GEORGIA WITH OTHER COUNTRIES. (external link)
• Hall, Trygve Sørdahl; Lueder, Thomas Gero von; Zannad, Faïez et al. (2019). Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction. (external link)
• Santema, Bernadet T.; Chan, Michelle M.Y.; Tromp, Jasper et al. (2019). The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. (external link)
• Docherty, Kieran F.; Shen, Li; Castagno, Davide et al. (2019). Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. (external link)
• Wal, Haye H. van der; Beverborg, Niels Grote; Dickstein, Kenneth et al. (2019). Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. (external link)
• Emmens, Johanna Elisabeth; Maaten, Jozine M. ter; Damman, Kevin et al. (2019). Proenkephalin, an opioid system surrogate, as a novel comprehensive renal marker in heart failure. (external link)
• Cao, Thong H.; Jones, Donald J.L.; Voors, Adriaan A. et al. (2019). Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. (external link)
• Howlett, Jonathan; Comin-Colet, Josep; Dickstein, Kenneth et al. (2018). Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey. (external link)
• Maaten, Jozine M. ter; Voors, Adriaan A.; Damman, Kevin et al. (2018). Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. (external link)
• Ferreira, João Pedro; Duarte, Kévin; Pitt, Bertram et al. (2018). Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: Findings from the EPHESUS and OPTIMAAL trials. (external link)
• Lovev, Svetoslav; Staneva, Milena; Dickstein, Kenneth et al. (2018). European crt survey II - bulgarian data. (external link)
• Tayal, Bhupendar; Gorcsan, John; Bax, Jeroen J. et al. (2018). Cardiac resynchronization therapy in patients with heart failure and narrow QRS complexes. (external link)
• Cano, Óscar; Bellver, Alejandro; Fontenla, Adolfo et al. (2018). Spanish results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II). (external link)
• Ferreira, João Pedro; Girerd, Nicolas; Gregson, John et al. (2018). Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation. (external link)
• Frikha, Zied; Ferreira, João Pedro; Bozec, Erwan et al. (2018). Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative). (external link)
• Tromp, Jasper; Ouwerkerk, Wouter; Demissei, Biniyam G. et al. (2018). Novel endotypes in heart failure: effects on guideline-directed medical therapy. (external link)
• Kristensen, Søren Lund; Mogensen, Ulrik M.; Tarnesby, Georgia et al. (2018). Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial. (external link)
• Wagenaar, Kim P.; Broekhuizen, Berna D.L.; Jaarsma, Tiny et al. (2018). Effectiveness of the European Society of Cardiology/Heart Failure Association website 'heartfailurematters.org' and an e-health adjusted care pathway in patients with stable heart failure: results of the 'e-Vita HF' randomized controlled trial. (external link)
• Cosmi, Franco; Shen, Li; Magnoli, Michela et al. (2018). Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. (external link)
• Dickstein, Kenneth; Normand, Camilla Jaqueline Hansine; Auricchio, Angelo et al. (2018). CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how?. (external link)
• Streng, Koen W.; Nauta, Jan F.; Hillege, Hans L. et al. (2018). Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. (external link)
• Ferreira, João Pedro; Metra, Marco; Mordi, Ify et al. (2018). Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study. (external link)
• Beusekamp, Joost C.; Tromp, Jasper; Wal, Haye H. van der et al. (2018). Potassium and the use of renin?angiotensin?aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF. (external link)
• Cao, Thong Huy; Jones, Donald J.L.; Quinn, Paulene A. et al. (2018). Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. (external link)
• Ferreira, João Pedro; Rossignol, Patrick; Demissei, Biniyam et al. (2018). Coronary angiography in worsening heart failure: Determinants, findings and prognostic implications. (external link)
• Santema, Bernadet T.; Kloosterman, Mariëlle; Gelder, Isabelle C. Van et al. (2018). Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. (external link)
• Brusich, Sandro; Zeljković, Ivan; Pavlovic, Nikola et al. (2018). Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry. (external link)
• Zeljkovic, Ivan; Burri, Haran; Breitenstein, Alexander et al. (2018). Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in Switzerland. (external link)
• Bulava, Alan; Hájek, Přemysl; Kautzner, Josef et al. (2018). Cardiac resynchronization therapy in the Czech Republic - Data from the EHRA CRT Survey II multicenter registry. (external link)
• Hall, Trygve Sørdahl; Lueder, Thomas Gero von; Zannad, Faiez et al. (2018). Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. (external link)
• Dobre, Daniela; Kjekshus, John; Rossignol, Patrick et al. (2018). Heart rate, pulse pressure and mortality in patients with myocardial infarction complicated by heart failure. (external link)
• Linde, Cecilia M.; Normand, Camilla Jaqueline Hansine; Bogale, Nigussie et al. (2018). Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. (external link)
• Emmens, Johanna Elisabeth; Jones, Donald J.L.; Cao, Thong H. et al. (2018). Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. (external link)
• Varma, Niraj; Søgaard, Peter; Bax, Jeroen J. et al. (2018). Interaction of left ventricular size and sex on outcome of cardiac resynchronization therapy among patients with a narrow QRS duration in the EchoCRT trial. (external link)
• Tromp, Jasper; Westenbrink, B. Daan; Ouwerkerk, Wouter et al. (2018). Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. (external link)
• Ouwerkerk, Wouter; Zwinderman, Aeilko H.; Ng, Leong L. et al. (2018). Biomarker-guided versus guideline-based treatment of patients with heart failure: Results from BIOSTAT-CHF. (external link)
• Suzuki, Toru; Yazaki, Yoshiyuki; Voors, Adriaan A. et al. (2018). Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure (from BIOSTAT-CHF). (external link)
• Dewan, Pooja; Jhund, Pardeep S.; Shen, Li et al. (2018). Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. (external link)
• Streng, Koen W.; Voors, Adriaan A.; Hillege, Hans L. et al. (2018). Waist-to-hip ratio and mortality in heart failure. (external link)
• Normand, Camilla Jaqueline Hansine; Linde, Cecilia; Singh, Jagmeet et al. (2018). Indications for cardiac resynchronization therapy: a comparison of the major international guidelines. (external link)
• Ferreira, João Pedro; Duarte, Kevin; Pfeffer, Marc A et al. (2018). Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative. (external link)
• Packer, Milton; Holcomb, Richard; Abraham, William T. et al. (2017). Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. (external link)
• Mogensen, Ulrik M.; Jhund, Pardeep S.; Abraham, William T. et al. (2017). Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction. (external link)
• Wagenaar, Kim P.; Rutten, Frans H.; Klompstra, Leonie Verheijden et al. (2017). 'heartfailurematters.org', an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions. (external link)
• Wolsk, Emil; Claggett, Brian; Pfeffer, Marc A. et al. (2017). Role of B-type natriuretic peptide and N-terminal prohormone BNP as predictors of cardiovascular morbidity and mortality in patients with a recent coronary event and type 2 diabetes mellitus. (external link)
• Bax, Jeroen J.; Delgado, Victoria; Søgaard, Peter et al. (2017). Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: A subanalysis of the randomized EchoCRT trial. (external link)
• Packer, Milton Ellen; O'Connor, Christopher M.; McMurray, John J.V. et al. (2017). Effect of ularitide on cardiovascular mortality in acute heart failure. (external link)
• Agewall, Stefan; Tjessem, Liv; Rossignol, Patrick et al. (2017). Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative. (external link)
• Voors, Adriaan A.; Ouwerkerk, Wouter; Zannad, Faiez et al. (2017). Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. (external link)
• Coiro, Stefano; Girerd, Nicolas; Rossignol, Patrick et al. (2017). Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative. (external link)
• Ferreira, João Pedro; Girerd, Nicolas; Duarte, Kevin et al. (2017). Serum chloride and sodium interplay in patients with acute myocardial infarction and heart failure with reduced ejection fraction: an analysis from the High-Risk Myocardial Infarction Database Initiative. (external link)
• Nägele, Matthias P.; Steffel, Jan; Robertson, Michele et al. (2017). Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT. (external link)
• Tajik, Athar Ali; Dobre, Daniela; Aguilar, David et al. (2017). A history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database. (external link)
• Shen, Li; Ramires, Felix; Martinez, Felipe et al. (2017). Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy. (external link)
• Ferreira, João Pedro; Rossignol, Patrick; Machu, Jean-Loup et al. (2017). Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. (external link)
• Skadberg, Øyvind; Kleiven, Øyunn; Bjørkavoll-Bergseth, Magnus et al. (2017). Highly increased Troponin i levels following high-intensity endurance cycling may detect subclinical coronary artery disease in presumably healthy leisure sport cyclists: The North Sea Race Endurance Exercise Study (NEEDED) 2013. (external link)
• Bayes-Genis, Antoni; Núñez, Julio; Zannad, Faiez et al. (2017). The PCSK9-LDL receptor axis and outcomes in heart failure: BIOSTAT-CHF subanalysis. (external link)
• Coiro, Stefano; Girerd, Nicolas; Rossignol, Patrick et al. (2017). Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative. (external link)
• Kristensen, Søren Lund; Jhund, Pardeep S.; Mogensen, Ulrik M. et al. (2017). Prognostic value of N-terminal pro-B-type natriuretic peptide levels in heart failure patients with and without atrial fibrillation. (external link)
• Wollert, Kai C.; Meyer, Gerd P.; Müller-Ehmsen, Jochen et al. (2017). Intracoronary autologous bone marrow cell transfer after myocardial infarction: The BOOST-2 randomised placebo-controlled clinical trial. (external link)
• Ouwerkerk, Wouter; Voors, Adriaan A.; Anker, Stephan D. et al. (2017). Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: A prospective European study. (external link)
• Steffel, Jan; Varma, Niraj; Robertson, Michele et al. (2016). Effect of gender on outcomes after cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. (external link)
• McMurray, John J.V.; Krum, Henry; Abraham, William T. et al. (2016). Aliskiren, enalapril, or aliskiren and enalapril in heart failure. (external link)
• Teerlink, John R.; Felker, G. Michael; McMurray, John J.V. et al. (2016). Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study. (external link)
• Gorcsan, John; Søgaard, Peter; Bax, Jeroen J. et al. (2016). Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: A subgroup analysis of the EchoCRT trial. (external link)
• Voors, Adriaan A.; Anker, Stefan D.; Cleland, John G. et al. (2016). A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF. (external link)
• Asphaug, Marte; Skadberg, Øyvind; Dalen, Ingvild et al. (2016). Natriuretic peptide levels taken following unplanned admission to a cardiology department predict the duration of hospitalization. (external link)
• Tajik, Athar Ali; Dickstein, Kenneth (2016). What constitutes optimal neurohumoral antagonism in chronic heart failure?. (external link)
• Ferreira, João Pedro; Girerd, Nicolas; Pellicori, Pierpaolo et al. (2016). Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. (external link)
• Cooper, Trond Johan; Anker, Stefan D.; Comin-Colet, Josep et al. (2016). Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia. (external link)
• Singsaas, Erlend Gyllensten; Manhenke, Cord A; Dickstein, Kenneth et al. (2016). Circulating galectin-3 levels are increased in patients with ischemic heart disease, but are not influenced by acute myocardial infarction. (external link)
• Abdul-Rahim, Azmil H; Docherty, Kieran F; Skali, Hicham et al. (2016). Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT. (external link)
• Störk, Stefan; Kavoliuniene, Ausra; Vinereanu, Dragos et al. (2016). What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative. (external link)
• Metra, Marco; Mentz, Robert J.; Hernandez, Adrian F. et al. (2016). Geographic differences in patients in a global acute heart failure clinical trial (from the ASCEND-HF Trial). (external link)
• Krum, Henry; McMurray, John J.V.; Abraham, William T. et al. (2015). The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): Revised statistical analysis plan and baseline characteristics. (external link)
• Bentley-Lewis, Rhonda; Aguilar, David; Riddle, Matthew C. et al. (2015). Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. (external link)
• Wagenaar, Kim P.; Broekhuizen, Berna D.L.; Dickstein, Kenneth et al. (2015). Effectiveness of an interactive platform, and the ESC/HFA heartfailurematters.org website in patients with heart failure: Design of the multicentre randomized e-Vita heart failure trial. (external link)
• Pfeffer, Marc A.; Claggett, Brian; Diaz, Rafael et al. (2015). Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. (external link)
• Steffel, Jan; Robertson, Michele; Singh, Jagmeet P. et al. (2015). The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: A subgroup analysis of the EchoCRT trial. (external link)
• Filippatos, Gerasimos; Khan, Sadiya Sana; Ambrosy, Andrew P. et al. (2015). International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): Rationale for and design of a global registry. (external link)
• Lueder, Thomas Gero von; Girerd, Nicolas; Atar, Dan et al. (2015). Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.. (external link)
• Ponikowski, Piotr; Filippatos, Gerasimos; Colet, Josep Comin et al. (2015). The impact of intravenous ferric carboxymaltose on renal function: An analysis of the FAIR-HF study. (external link)
• Mebazaa, Alexandre; Yilmaz, M. Birhan; Levy, Phillip et al. (2015). Recommendations on pre-hospital & early hospital management of acute heart failure: A consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. (external link)
• Jaarsma, Tiny; Klompstra, Leonie Verheijden; Gal, Tuvia Ben et al. (2015). Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: The rationale, design and methodology of the HF-Wii study; A multicentre randomized controlled trial. (external link)
• Khazanie, Prateeti; Heizer, Gretchen M.; Hasselblad, Vic et al. (2015). Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models. (external link)
• Manhenke, Cord A; Ueland, Thor; Jugdutt, Bodh I. et al. (2014). The relationship between markers of extracellular cardiac matrix turnover: Infarct healing and left ventricular remodelling following primary PCI in patients with first-time STEMI. (external link)
• Ketchum, Eric S.; Dickstein, Kenneth; Kjekshus, John et al. (2014). The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction. (external link)
• Deursen, Vincent M. van; Hernandez, Adrian F.; Stebbins, Amanda et al. (2014). Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).. (external link)
• Melberg, Tor Harald; Jørgensen, Marianne; Ørn, Stein et al. (2014). Safety and health status following early discharge in patients with acute myocardial infarction treated with primary PCI: a randomized trial. (external link)
• Patel, Priyesh A.; Heizer, Gretchen M; O’Connor, Christopher M. et al. (2014). Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality findings from ASCEND-HF. (external link)
• Dickstein, Kenneth; Normand, Camilla Jaqueline Hansine; Anker, Stefan D. et al. (2014). European Cardiac Resynchronization Therapy Survey II: rationale and design. (external link)
• Moukarbel, George V; Yu, Zi-Fan; Dickstein, Kenneth et al. (2014). The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients. (external link)
• Nieminen, Markku Sakari; Altenberger, Johann; Ben-Gal, Tuvia et al. (2014). Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus. (external link)
• Comin-Colet, Josep; Lainscak, Mitja; Dickstein, Kenneth et al. (2013). The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. (external link)
• Filippatos, Gerasimos; Farmakis, Dimitrios; Colet, Josep Colin et al. (2013). Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (external link)
• Ruschitzka, Frank; Abraham, William T.; Singh, Jagmeet et al. (2013). Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. (external link)
• Manhenke, Cord A; Ørn, Stein; Haehling, Stephan von et al. (2013). Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction. (external link)
• Inglis, Sally C.; Bebchuk, Judith; Al-Suhaim, Sultan A. et al. (2013). Peripheral artery disease and outcomes after myocardial infarction: An individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. (external link)
• Cooper, Trond Johan; Guazzi, Marco; Al-Mohammad, Abdallah et al. (2013). Sildenafil in Heart Failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and design. (external link)
• Sohaib, S.M. Afzel; Chen, Zhongbo; Whinnett, Zachary I. et al. (2013). Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy. (external link)
• Gullestad, Lars; Ørn, Stein; Dickstein, Kenneth et al. (2013). Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction. (external link)
• Howlett, Jonathan G.; Ezekowitz, Justin A.; Podder, Mohua et al. (2013). Global variation in quality of care among patients hospitalized with acute heart failure in an international trial findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF). (external link)
• Larsen, Alf Inge; Lindal, Sigurd; Myreng, Kate et al. (2013). Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation. (external link)
• Hu, Da-Yi; Huang, Jun; Cai, Nai-sheng et al. (2012). A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment. (external link)
• Yndestad, Arne; Finsen, Alexandra; Ueland, Thor et al. (2012). The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure. (external link)
• Gravning, Jørgen A.; Ørn, Stein; Kaasbøll, Ole Jørgen et al. (2012). Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction. (external link)
• McMurray, John J.; Anker, Stefan D; Auricchio, Angelo et al. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic HeartFailure 2012 of the European Society of Cardiology. Developed in collaborationwith the Heart Failure Association (HFA) of the ESC. (external link)
• Conraads, Viviane M.; Deaton, Christi; Piotrowicz, Ewa et al. (2012). Adherence of heart failure patients to exercise: barriers and possible solutions A position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology. (external link)
• Ørn, Stein; Ueland, Toril; Manhenke, Cord A et al. (2012). Increased interleukin-1 beta levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention. (external link)
• Kiernan, Michael S; Wentworth, Deborah; Francis, Gary et al. (2012). Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial. (external link)
• Felker, G. Michael; Hasselblad, Vic; Tang, W.H. Wilson et al. (2012). Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. (external link)
• McMurray, JJ; Adamopoulos, Stamatis; Anker, S D et al. (2012). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic HeartFailure 2012 of the European Society of Cardiology. Developed in collaborationwith the Heart Failure Association (HFA) of the ESC. (external link)
• Daubert, Jean-Claude; Saxon, Leslie; Adamson, Philip B et al. (2012). 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. (external link)
• Daubert, Jean-Claude; Saxon, Leslie; Adamson, Philip B et al. (2012). 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. (external link)
• Bogale, Nigussie; Priori, Silvia Giuliana; Cleland, John G.F. et al. (2012). The European CRT Survey: 1 year (9-15 months) follow-up results. (external link)
• Steg, Philippe Gabriel; James, Stefan; Atar, Dan et al. (2012). ESC Guidelines for the management of acute myocardial infarction in patientspresenting with ST-segment elevation. (external link)
• O'Connor, Christopher M.; Starling, RC; Hernandez, AF et al. (2011). Effect of nesiritide in patients with acute decompensated heart failure. (external link)
• Bogale, Nigussie; Priori, Silvia Giuliana; Gitt, Anselm et al. (2011). The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume. (external link)
• Piepoli, Massimo F; Conraads, Viviane; Corra, Ugo et al. (2011). Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. (external link)
• Lainscak, Mitja; Blue, Lynda; Clark, Andrew L. et al. (2011). Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. (external link)
• Krum, Henry; Massie, Barry; Abraham, William T. et al. (2011). Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. (external link)
• Manhenke, Cord Arend; Ørn, Stein; Squire, Ian et al. (2011). The prognostic value of circulating markers of collagen turnover after acute myocardial infarction. (external link)
• Bogale, Nigussie; Witte, Klaus; Priori, Silvia Giuliana et al. (2011). The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. (external link)
• Klip, I Jsbrand T; Voors, Adriaan A.; Anker, Stefan D et al. (2011). Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. (external link)
• Dickstein, Kenneth; Vardas, Panos E.; Auricchio, Angelo et al. (2010). 2010 Focused Update of ESC Guidelines on device therapy in heart failure. (external link)
• Dickstein, Kenneth; Vardas, Panos E.; Auricchio, Angelo (2010). 2010 Focused Update of ESC Guidelines on device therapy in heart failure. (external link)
• Dickstein, Kenneth; Vardas, Panos E.; Auricchio, Angelo et al. (2010). Update of ESC guidelines regarding usage of devices in patients with heart failure-2010. (external link)
• Felker, G. Michael; Pang, Peter S.; Adams, Kirkwood F. et al. (2010). Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward. (external link)
• Harjola, Veli-Pekka; Follath, Ferenz; Nieminen, Markku S. et al. (2010). Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. (external link)
• Dickstein, Kenneth; Vardas, Panos E.; Auricchio, Angelo et al. (2010). 2010 Focused Update of ESC Guidelines on device therapy in heart failure An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. (external link)
• Dickstein, Kenneth; Vardas, Panos E.; Auricchio, Angelo et al. (2010). 2010 Focused Update of ESC Guidelines on device therapy in heart failure. (external link)
• Melberg, Tor; Burman, Robert Anders; Dickstein, Kenneth (2010). The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: A retrospective cohort study. (external link)
• Ørn, Stein; Orn, S; Manhenke, Cord Arend et al. (2009). C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. (external link)
• Voors, Adriaan A.; Haehling, Stephan von; Anker, Stefan D. et al. (2009). C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. (external link)
• Komajda, Michel; Hanon, Olivier; Hochadel, Matthias et al. (2009). Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. (external link)
• Dickstein, Kenneth; Bogale, Nigussie; Priori, Silvia Giuliana et al. (2009). The European cardiac resynchronization therapy survey. (external link)
• Anker, Stefan D.; Voors, Adriaan A.; Okonko, Darlington et al. (2009). Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. (external link)
• Larsen, Alf Inge; Skadberg, Øyvind; Aarsland, Torbjørn et al. (2009). B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure. (external link)
• Anker, Stefan D.; Colet, Joseph C; Filippatos, Gerasimos et al. (2009). Rationale and design of Ferinject((R)) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. (external link)
• Veldhuisen, Dirk J. van; Maass, Alexander H; Priori, Silvia Giuliana et al. (2009). Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. (external link)
• Brügger-Andersen, Trygve; Pönitz, Volker; Snapinn, Steven M. et al. (2009). Moderate alcohol consumption is associated with reduced long-term cardiovascular risk in patients following a complicated acute myocardial infarction. (external link)
• Yndestad, A; Landrø, Linn; Ueland, Thor et al. (2009). Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. (external link)
• Dickstein, Kenneth; Priori, Silvia Giuliana; Auricchio, Angelo et al. (2009). European cardiac resynchronization therapy survey: rationale and design. (external link)
• Konstam, Marvin A; Neaton, James D.; Dickstein, Kenneth et al. (2009). Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. (external link)
• Anker, Stefan D.; Colet, Joseph C; Filippatos, Gerasimos et al. (2009). Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. (external link)
• Guazzi, Marco; Dickstein, Kenneth; Vicenzi, Marco et al. (2009). Six-Minute Walk Test and Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure A Comparative Analysis on Clinical and Prognostic Insights. (external link)
• Mitrovic, Veselin; Seferovic, Petar; Dodic, Slobodan et al. (2009). Cardio-Renal Effects of the A1 Adenosine Receptor Antagonist SLV320 in Patients With Heart Failure. (external link)
• Ørn, Stein; Breland, Unni M.; Mollnes, Tom Eirik et al. (2009). The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial Infarction. (external link)
• Orn, S; Ørn, Stein; Manhenke, Cord Arend et al. (2009). Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. (external link)
• Hernandez, Adrian F.; O'Connor, Christopher M.; Starling, Randall C. et al. (2009). Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). (external link)
• Larsen, Alf Inge; Skadberg, Øyvind; Aarsland, Torbjørn et al. (2009). B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure. (external link)
• Belonje, Anne M.S.; Westenbrink, B. Daan; Voors, Adriaan A. et al. (2009). Erythropoietin levels in heart failure after an acute myocardial infarction: Determinants, prognostic value, and the effects of captopril versus losartan. (external link)
• Larsen, Alf Inge; Helle, Karen Blaauw; Christensen, Monika et al. (2008). Effect of exercise training on chromogranin A and relationship to N-ANP and inflammatory cytokines in patients with chronic heart failure. (external link)
• Nieminen, Markku S.; Harjola, Veli-Pekka; Hochadel, Matthias et al. (2008). Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. (external link)
• Mann, Johannes FE; Schmieder, Roland E; McQueen, Matthew et al. (2008). Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. (external link)
• Konstam, Marvin A; Poole-Wilson, Philip Alexander; Dickstein, Kenneth et al. (2008). Design of the Heart failure Endpoint evaluation of AII-Antagonist Losartan (HEAAL) study in patients intolerant to ACE-inhibitor. (external link)
• Torp-Pedersen, Christian; Køber, Lars; Carlsen, Jan E. et al. (2008). A randomised trial of a pre-synaptic stimulator of DA(2)-dopaminergic and alpha(2)-adrenergic receptors on morbidity and mortality in patients with heart failure. (external link)
• Bogale, Nigussie; Ørn, Stein; James, Margaret K. et al. (2007). Usefulness of either or both left and right bundle branch block at baseline or during follow-up for predicting death in patients following acute myocardial infarction. (external link)
• Gustafsson, Ida; Kistorp, Caroline N.; James, Margaret K. et al. (2007). Unrecognized glycometabolic disturbance as measured by hemoglobin A(1c) is associated with a poor outcome after acute myocardial infarction. (external link)
• Ørn, Stein; Manhenke, Cord Arend; Squire, Iain B. et al. (2007). Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: Relation to cardiac magnetic resonance imaging measures of left ventricular structure and function. (external link)
• Orn, S; Ørn, Stein; Manhenke, Cord Arend et al. (2007). Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. (external link)
• Dickstein, Kenneth; Gleim, Gilbert W.; Snappin, Steven et al. (2006). The impact of morbid events on survival following hospitalization for complicated myocardial infarction. (external link)
• Larsen, Alf Inge; Dickstein, Kenneth; Ahmadi, Seyed Nasser et al. (2006). The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure. (external link)
• Ueland, Thor; Espevik, Terje; Kjekshus, John et al. (2006). Mannose binding lectin and soluble Toll-lilke receptor 2 in heart failure following acute myocardial infarction. (external link)
• Estensen, Mette Elise; Hognestad, Aina; Syversen, Unni et al. (2006). Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction. (external link)
• Busch, Michael; Søreide, Eldar; Lossius, Hans Morten et al. (2006). Rapid implementation of therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. (external link)
• Bonarjee, Vernon V.S; Rosengren, Annika; Snapinn, Steven M. et al. (2006). Sex-based short- and long-term survival in patients following complicated myocardial infarction. (external link)
• Ueland, Thor; Aukrust, Pål; Yndestad, Arne et al. (2005). Soluble CD40 ligand in acute and chronic heart failure. (external link)
• Konstam, Marvin A.; Neaton, James D.; Poole-Wilson, Philip A. et al. (2005). Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). (external link)
• Ueland, Thor; Aukrust, Pål; Yndestad, Arne et al. (2005). Soluble CD40 ligand in acute and chronic heart failure. (external link)
• Ørn, Stein; Orn, S; Cleland, John G.F. et al. (2005). Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction. (external link)
• Larsen, Alf Inge; Dickstein, Kenneth (2005). Exercise training in congestive heart failure. A review of the current status. (external link)
• Squire, Iain B.; Ørn, Stein; Ng, Leong L. et al. (2005). Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy. (external link)
• Ueland, Thor; Kjekshus, John; Frøland, Stig Sophus et al. (2005). Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. (external link)
• Dickstein, Kenneth (2005). Is eplerenone a cost-effective therapy for heart failure patients after myocardial infarction?. (external link)
• Malmberg, K.; Rydén, L.; Wedel, H et al. (2005). Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. (external link)
• Lehto, Mika; Snapinn, Steven M.; Dickstein, Kenneth et al. (2005). Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAL experience. (external link)
• Larsen, AI; Gjesdal, K; Hall, Christian et al. (2004). Effect of exercise training in patients with heart failure: a pilot study on autonomous balance assessed by heart rate variability. (external link)
• Ueland, Thor; Jemtland, Rune; Godang, Kristin et al. (2004). Prognostic value of osteoprotegerin in heart failure following acute myocardial infarction. (external link)
• Larsen, Alf Inge; Gjesdal, Clara Gram; Hall, C. et al. (2004). Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability. (external link)
• Ueland, Thor; Jemtland, Rune; Godang, Kristin et al. (2004). Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. (external link)
• Anavekar, NS; McMurray, JJV; Velazquez, EJ et al. (2004). Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. (external link)
• Dickstein, Kenneth; Kjekshus, John (2004). Effects of losartan and captopril on morbidity and mortality after acute MI. (external link)
• Jaatun, H.; Sutradhar, S.; Dickstein, Kenneth (2004). Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers. (external link)
• Pocock, S.; Wilhelmsen, L.; Dickstein, Kenneth et al. (2004). The data monitoring experience in the MOXCON trial. (external link)
• Dickstein, Kenneth; Voogd, H.J.; Miric, M.P. et al. (2004). Effect of single doses of SLV306, an inhibitor of both neutral enclopepticlase and enclothelin-converting enzyme, on pulmonary pressures in congestive heart failure. (external link)
• Hognestad, A; Dickstein, K; Myhre, Eivind S.p. et al. (2004). Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure. (external link)
• Larsen, Alf Inge; Hall, Christian; Aukrust, Pål et al. (2003). Prognostic usefulness of an increase in N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure. (external link)
• Omland, Torbjørn; Dickstein, Kenneth; Syversen, Unni (2003). Plasma chromogranin A concentration as an indicator of long-term mortality after acute myocardial infarction. (external link)
• Ørn, Stefan; Dickstein, Kenneth (2003). Neurohumoral inhibition in heart failure; is there no limit?. (external link)
• Hall, Christian; Ihlen, Halfdan; Bonarjee, Vernon et al. (2003). N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease. (external link)
• Omland, T; Dickstein, K; Syversen, Unni (2003). Association between plasma chromogranin A concentration and long-term mortality after myocardial infarction. (external link)
• Larsen, Alf Inge; Hall, Christian; Aukrust, Pål et al. (2003). Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure. (external link)
• Omland, Torbjørn; Dickstein, Kenneth; Syversen, Unni (2003). Association between plasma chromogranin A and long-term mortality after myocardial infarction. (external link)
• Hall, Christian; Ihlen, Halfdan; Bonarjee, Vernon et al. (2003). N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease. (external link)
• Dickstein, Kenneth; Kjekshus, John (2002). For the OPTIMAAL trial: losartan or captopril after acute myocardial infarction. (external link)
• Dickstein, Kenneth; Kjekshus, John (2002). Effects of losatan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. (external link)
• Hetland, Øyvind; Knudsen, Anette; Dickstein, Kenneth et al. (2002). Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease. (external link)
• Larsen, Alf Inge; Lindal, Sigurd; Aukrust, Pål et al. (2002). Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. (external link)
• Dickstein, Kenneth; Kjekshus, John (2002). Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. (external link)
• Sørbye, Torgeir W.; Ellingsen, Christian L.; Dickstein, Kenneth (2002). Prioritering av sykehusobduksjon. (external link)
• Ørn, Stein; Dickstein, Kenneth (2002). How do heart failure patients die?. (external link)
• Dickstein, Kenneth (2001). AllAs in congestive heart failure: Insights from ELITE II and ValHeft. (external link)
• Dickstein, Kenneth; Kjekshus, J. (2001). Comparison of baseline data, initial course, and management: Losartan vs. Captopril following acute myocardial infarction (The OPTIMAAL Trial). (external link)
• Hetland, Ø.; Dickstein, Kenneth; Nilsen, D. (2001). Fibrin monomer (soluble fibrin) as a marker of coagulation activation in patients with acute chest pain syndromes. (external link)
• Dickstein, Kenneth; Aarsland, T.; Hapnes, R. (2001). Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma. (external link)
• Larsen, A.; Aarsland, T.; Kristiansen, M. et al. (2001). Assessing the effect of exercise training in men with heart failure. Comparison of maximal, submaximal and endurance protocols. (external link)
• Dickstein, Kenneth (2001). The role of losartan in the management of patients with heart failure. (external link)
• Bonarjee, V.; Dickstein, Kenneth (2001). How long should ACE inhibitors be given to patients following myocardial infarction: Implications of HOPE. (external link)
• Larsen, A. I.; Aukrist, P.; Aarsland, T. et al. (2001). Effect of aerobic exercise training on plasma levels of tumor necosis factor alpha in patients with heart failure. (external link)
• Manhenke, Cord Arend; Dickstein, Kenneth (2001). Digitalis ved hjertesvikt - fortsatt et aktuelt behandlingsprinsipp?. (external link)
• Hegland, Øivind; Dickstein, Kenneth; Larsen, Jan P. (2001). Effect of simvastatin in preventing progression of carotid artery stenosis. (external link)
• Dickstein, Kenneth (2001). ELITE II and ValHeft; Together what do they tell us?. (external link)
• Dickstein, Kenneth; Kjekshus, John (2001). Comparison of baseline data, Initial course, and mannagment: Losartan Versus captopril following acute myocardial infarction (The OPTIMAAL Trial). (external link)
• Ørn, S; Dickstein, Kenneth (2000). Pharmacotherapy following myocardial infarction - a review of current treatment practices. (external link)
• Swedberg, K; Dickstein, Kenneth; Bergh, C et al. (2000). Effects of moxonidine, a novel imidazoline agonist, on plasma norepinephrine in patients with congestive heart failure. (external link)
• Pitt, P; Poole-Wilson, P; Segal, R et al. (2000). Randomised trial of losartan versus captopril on mortality in patients with symptomatic heart failure: the Losartan Heart Failure Survival Study - ELITE II. (external link)
• Tollefsen, N; Dickstein, Kenneth (2000). Er øyeblikkelig hjelp-innleggelser i medisinks avdeling avhengig av været?. (external link)
• Pitt, P; Poole-Wilson, P; Segal, R et al. (2000). Randomised trial of losartan versus captopril on mortality in patients with symptomatic heart failure: the Losartan Heart Failure Survival Study - ELITE II. (external link)
• Tollefsen, N; Dickstein, Kenneth (2000). Are emergency medical admissions dependent on the weather?. (external link)
• Swedberg, K; Dickstein, Kenneth; Bergh, C et al. (2000). Effects of moxonidine, a novel imidazoline agonist, on plasma norepinephrine in patients with congestive heart failure. (external link)
• Hegland, Ø; Dickstein, Kenneth; Larsen, J (2000). Effect of simvastatin in preventing progression of carotid artery stenosis. (external link)
• Omland, T; Dickstein, Kenneth; Bonarjee, V et al. (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. (external link)
• Dickstein, Kenneth; Manhenke, C; Aarsland, T et al. (2000). The Effects of Chronic, Sustained-release Moxonidine Therapy on Clinical and Neurohumoral Status in Patients with Heart Failure. (external link)
• Bonarjee, V; Dickstein, Kenneth (2000). The use of angiotensin II receptor antagonists in heart failure. (external link)
• Larsen, A; Aarsland, T; Dickstein, Kenneth (2000). Effects of exercise training on maximal and submaximal endurance capacity in men with congestive heart failure. (external link)
• Ørn, S; Dickstein, Kenneth (2000). Pharmacotherapy following myocardial infarction - a review of current treatment practices. (external link)
• Dickstein, Kenneth; Kjekshus, J (2000). Losartan vs. Captopril in patients following Acute Myocardial Infarction: The OPTIMAL Trial Design. (external link)
• Poole-Wilson, P; Segal, R; Konstam, M et al. (2000). Improvements in quality of life of symptomatic heart failure patients treated long-term with losartan and captopril: the ELITE II quality of life substudy. (external link)
• Omland, T; Dickstein, Kenneth; Syversen, U (2000). Plasma chromogranin A is an independent predictor of survival after acute myocardial infarction. (external link)
• Larsen, A; Aarsland, T; Dickstein, Kenneth (2000). Effect of aerobic exercise training on cytokine levels in patients with congestive heart failure. (external link)
• Dickstein, Kenneth (2000). Angiotensin II antagonists are superior to ACE inhibitors. David versus Golitah. (external link)
• Dickstein, Kenneth (2000). Exercise training in heart failure. Time to go beyond surrogate endpoints. (external link)
• Dickstein, Kenneth; Kjekshus, J (2000). Losartan vs. Captopril in patients following Acute Myocardial Infarction: The OPTIMAL Trial Design. (external link)
• Dickstein, Kenneth; Manhenke, C; Aarsland, T et al. (2000). The Effects of Chronic, Sustained-release Moxonidine Therapy on Clinical and Neurohumoral Status in Patients with Heart Failure. (external link)
• Bonarjee, V; Dickstein, Kenneth (2000). Bruk av angiotensin II - reseptorblokkere ved hjertesvikt. (external link)
• Dickstein, Kenneth (2000). Angiotensin II antagonists are superior to ACE inhibitors. David versus Golitah. (external link)
• Dickstein, Kenneth (2000). Exercise training in heart failure. Time to go beyond surrogate endpoints. (external link)
• Dickstein, Kenneth; Kjekshus, John (1999). Comparison of the effects of Losartan and Captopril on mortality in patients after acute myocardial infarction: The OPTIMAAL Trial Design. (external link)
• Westheim, A. S.; Dickstein, Kenneth; Gundersen, Thomas Erik et al. (1999). Kronisk hjertesvikt - forslag til handlingsprogram. (external link)
• Gundersen, Thomas Erik; Dickstein, Kenneth; Hole, Torstein et al. (1997). Betablokkerbehandling av hjertesviktpasienter. (external link)
• Gundersen, Thomas Erik; Dickstein, Kenneth; Hole, Torstein et al. (1997). Treatment of heart failure with beta-adrenergic blocking drugs. (external link)
• Hole, Torstein; Dickstein, Kenneth; Gundersen, Thomas Erik et al. (1997). Calcium channel blockers in heart failure. (external link)
• Dickstein, Kenneth; Aarsland, Torbjørn; Hall, Christian (1997). Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure. (external link)
• Klinge, Randi Furseth; Polis, A.; Dickstein, Kenneth et al. (1997). Effects of angiotensin II receptor blockage on N- terminal proatrial natriuretic factor plasma levels in chronic heart failure. (external link)
• Gjesdal, Knut; Dickstein, Kenneth (1997). Digitalis - et gammelt, men stadig aktuelt medikament. (external link)
• Dickstein, Kenneth; Larsen, AI; Bonarjee, Vernon et al. (1996). Pro-atrial natriuretisk faktor i plasma er prediktiv for klinisk status hos hjertesviktpasienter. (external link)
• Omland, T; Aarsland, T; Aakvaag, A et al. (1993). The effect of early converting enzyme inhibition on neurohumoral activycation in acute myocardial infarction. (external link)

Reader opinion piece

• Gerstein, Hertzel C.; Wolsk, Emil; Claggett, Brian et al. (2022). Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. (external link)
• Cooper, Trond Johan; Pellicori, Pierpaolo; Ushakova, Anastasia et al. (2022). Reply to ‘Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease’. (external link)
• Tromp, Jasper; Ouwerkerk, Wouter; Cleland, John G.F. et al. (2022). A global perspective of racial differences and outcomes in patients presenting with acute heart failure. (external link)
• Tromp, Jasper; Bamadhaj, Sahiddah; Cleland, John G F et al. (2020). Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. (external link)
• Israr, Muhammad Zubair; Salzano, Andrea; Yazaki, Yoshiyuki et al. (2020). Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT-CHF. (external link)
• Wolsk, Emil; Claggett, Brian; Diaz, Rafael et al. (2017). Increases in natriuretic peptides precede heart failure hospitalization in patients with a recent coronary event and type 2 diabetes mellitus. (external link)
• McMurray, John J.V.; Dickstein, Kenneth; Køber, Lars V. (2016). Pioglitazone after ischemic stroke or transient ischemic attack: The authors reply. (external link)
• Dickstein, Kenneth (2009). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides: reply. (external link)
• Dickstein, Kenneth; McMurray, John J.V. (2009). Should beta-blockade continue to be withheld from patients with chronic heart failure and asthma? Reply. (external link)
• Larsen, Alf Inge; Skadberg, Øyvind; Aarsland, Torbjørn et al. (2008). B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure. (external link)
• Metra, Marco; Brutsaert, Dirk; Dickstein, Kenneth et al. (2007). Treatment of advanced chronic heart failure with normal left ventricular ejection fraction. Response to the letter by Dr. Martinez-Selles. (external link)
• Ørn, Stein; Dickstein, Kenneth (2007). Reduce the risk of reinfarction and related complications after myocardial infarction - The reply. (external link)
• Dickstein, Kenneth (2006). Clinical trials update from the European Society of Cardiology Meeting 2005: CIBIS-III. response to correspondence from R. Willenheimer et al. (external link)
• Kennedy, L; Dickstein, Kenneth; Anker, S. et al. (2005). The prognostic importance of body mass index after complicated myocardial infarction. (external link)
• Dickstein, Kenneth; Jaarsma, Tiny (2005). Heart failure management programmes: delivering the message. (external link)
• McMurray, J.; Swedberg, K; Pfeffer, M. et al. (2005). Angiotensin receptor blockers and myocardial infarction: Analysis of evidence is incomplete and inaccurate. (external link)
• Tuseth, V.; Jaatun, HJ; Dickstein, Kenneth (2005). Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment. (external link)
• Dickstein, Kenneth; Erdmann, Erland (2005). Establishing best practice in the management of chronic heart failure - Introduction. (external link)
• Dickstein, Kenneth (2004). Appearances can deceive: even brave hearts can fail. (external link)
• Larsen, Alf Inge; Dickstein, Kenneth (2004). Can sedentary patients with heart failure achieve the beneficial effect of exercise training without moving?. (external link)
• Larsen, Alf Inge; Dickstein, Kenneth (2004). BNP in acute coronary syndromes: the heart expresses its suffering. (external link)
• Dickstein, Kenneth; Kjekshus, John (2002). The OPTIMMAL trial: losartan or captopril after acute myocardial infarction. (external link)
• Dickstein, Kenneth (2002). Angiotensin receptor blockers-finally the evidence is coming in: IDNT and RENAAL. (external link)
• Dickstein, Kenneth (2001). The plight of the peer reviewer (letter). (external link)
• Dickstein, Kenneth (2001). Er det farlig å bli innlagt i helgen?. (external link)

Errata

• Santema, Bernadet T.; Chan, Michelle M. Y.; Tromp, Jasper et al. (2021). Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y). (external link)
• Ranganathan, Deepti; Sharif, Zain; Murphy, Theodore et al. (2020). Correction to: CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy—an Irish subset analysis (Irish Journal of Medical Science (1971 -), (2020), 189, 3, (895-905), 10.1007/s11845-020-02173-y). (external link)

Academic literature review

• Knuuti, Juhani; Wijns, William; Saraste, Antti et al. (2020). 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. (external link)
• Normand, Camilla Jaqueline Hansine; Kaye, David M.; Povsic, Thomas J. et al. (2019). Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. (external link)
• Piotrowicz, Ewa; Piepoli, Massimo F.; Jaarsma, Tiny et al. (2016). Telerehabilitation in heart failure patients: The evidence and the pitfalls. (external link)
• Nieminen, Markku S.; Dickstein, Kenneth; Fonseca, Cândida et al. (2015). The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations. (external link)
• Zannad, Faiez; Garcia, Angeles Alonso; Anker, Stefan D. et al. (2013). Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. (external link)
• Dickstein, Kenneth; Bebchuk, Judith; Wittes, Janet (2012). The High-Risk Myocardial Infarction Database Initiative. (external link)
• Gheorghiade, Mihai; Follath, Ferenz; Ponikowski, Piotr et al. (2010). Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. (external link)
• Dickstein, Kenneth (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). (external link)
• Dickstein, Kenneth; Cohen-Solal, Alain; Filippatos, Gerasimos et al. (2008). Guidelines 2008 European Society of Cardiology on the diagnosis and treatment of acute and chronic heart failure. (external link)
• Dickstein, Kenneth; Cohen-Solal, Alain; Filippatos, Gerasimos et al. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. (external link)
• Luca, Leonardo De; Mebazaa, Alexandre; Filippatos, Gerasimos et al. (2008). Overview of emerging pharmacologic agents for acute heart failure syndromes. (external link)
• Dickstein, K; Cohen-Solal, A; Filippatos, G et al. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). (external link)
• Swedberg, Karl; Cleland, John; Cowie, Martin R. et al. (2008). Successful treatment of heart failure with devices requires collaboration. (external link)
• Metra, Marco; Ponikowski, Piotr; Dickstein, Kenneth et al. (2007). Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. (external link)
• Dickstein, Kenneth (2005). Diagnosis and assessment of the heart failure patient: the cornerstone of effective management. (external link)

Poster

• Hall, Trygve Sørdahl; Orn, S; Zanned, F. et al. (2020). The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction. (external link)
• Ørn, Stein; Manhenke, C; Bonarjee, Vernon et al. (2007). Temporal changes between infarct size and ejection fraction following primary PCI assessed by cardiac magnetic resonance. (external link)
• Dickstein, Kenneth; Snapinn, Steven M. (2002). Prediction of mortality and morbidity following myocardial infarction. (external link)
• Ørn, Stein; Cleland, John; Kjekshus, John et al. (2002). Myocardial infarction is the most common underlying cause of death in patients with heart failure following myocardial infarction. (external link)
• Nieminen, Markku; Zeiher, Andreas; Myhre, Eivind et al. (2002). The effect of revascularisation rate on prognosis of high-risk acute myocardial infarction patients. An OPTIMAAL substudy. (external link)
• Jaatun, Hans; Snapinn, Steven M.; Dickstein, Kenneth (2002). Smoking and cardiovascular risk following myocardial infarction. (external link)
• Hetland, Øyvind; Dickstein, Kenneth; Nilsen, Dennis W.t. (2001). Activation of coagulation in patients with acute chest pain syndromes as determined by fibrin monomer (soluble fibrin). (external link)
• Hegland, Ø.; Dickstein, Kenneth; Larsen, Jan P. (2001). Effect of simvastatin in preventing progression of carotid artery stenosis. (external link)
• Omland, T; Aakvaag, A; Bonarjee, VVS et al. (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. (external link)
• Omland, T; Aakvaag, A; Bonarjee, VVS et al. (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. (external link)

Academic chapter/article/Conference paper

• Normand, Camilla Jacqueline Hansine; Dickstein, Kenneth (2019). CRT Devices in Heart Failure: Does the Patient Need a Pacemaker or Defibrillator?. (external link)
• Pocock, Stuart; Wilhelmsen, Lars; Dickstein, Kenneth et al. (2006). Data Monitoring Experience in the Moxonidine Congestive Heart Failure Trial. (external link)
• Manhenke, Curt; Dickstein, Kenneth (2002). Heart failure and Coronary Artery Disease. (external link)

Editorial

• Normand, Camilla Jaqueline Hansine; Dickstein, Kenneth (2018). Guideline recommendations for cardiac resynchronization therapy evolve but does clinical practice match the pace?. (external link)
• Dickstein, Kenneth (2017). Early clinical benefit after cardiac resynchronization therapy: fortunately, QRS width and ejection fraction are still the best predictors. (external link)
• Steen, Torkel; Dickstein, Kenneth (2017). Do real world data support and extend our ability to predict reverse remodelling following cardiac resynchronization therapy based on QRS morphology and width?. (external link)
• Normand, Camilla Jaqueline Hansine; Dickstein, Kenneth (2016). Does the presence of mitral regurgitation strengthen or weaken the indication for cardiac resynchronization therapy?. (external link)
• Dickstein, Kenneth (2015). Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: Who has it and are we missing a potential therapeutic target in patients with heart failure?. (external link)
• Dickstein, Kenneth (2015). Is substantial renal dysfunction in patients with heart failure no longer a contraindication for RAS inhibition? the power of a large, high-quality registry to illuminate major clinical issues. (external link)
• Normand, Camilla Jaqueline Hansine; Dickstein, Kenneth (2015). Predicting outcomes following CRT: The quest continues. (external link)
• Dickstein, Kenneth (2013). Cardiac resynchronization therapy in seniors: when are we too old to deserve a device that makes us feel better and improves clinical outcomes?. (external link)
• Krum, Henry; Massie, Barrie; Abraham, William T. et al. (2013). Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE. (external link)
• McMurray, John J.V.; Abraham, William T.; Dickstein, Kenneth et al. (2012). Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. (external link)
• Dickstein, Kenneth (2012). Beware the dangers of the reply-all button. (external link)
• Dickstein, Kenneth (2011). Cardiac myosin activation: will theory and practice coincide?. (external link)
• Dickstein, Kenneth (2011). Chronic right ventricular pacing, adverse remodelling, and CRT: an ounce of prevention?. (external link)
• Dickstein, Kenneth (2010). Inpatients are sicker than outpatients; finally it's evidence-based. (external link)
• Dickstein, Kenneth (2010). Response to Coceani: Cardiac Resynchronization Therapy Has Earned Its Class I Recommendation and Continues to Thrive Under Scrutiny. (external link)
• Jaques, Helen; Dickstein, Kenneth (2010). Personal experiences of emigre cardiologist: Kenneth Dickstein MD, PhD, FESC A tale of enchantment. (external link)
• Nicholls, M; Dickstein, Kenneth (2009). Spotlight: Kenneth Dickstein, MD, PhD, FESC. (external link)
• Dickstein, Kenneth (2009). Diagnosing Acute Heart Failure. The Mathematician and the Clinician. (external link)
• Dickstein, Kenneth; Cohen-Solal, Alain; Filippatos, Gerasimos et al. (2008). ESC Guidelines for the Diagnosis And Treatment of Acute And Chronic Heart Failure 2008. (external link)
• Strömberg, Anna; Dickstein, Kenneth (2008). What is new and of special interest to nurses in the 2008 ESC guidelines for diagnosis and treatment of acute and chronic heart failure?. (external link)
• Dickstein, Kenneth (2005). C-reactive protein in ischaemic cardiomyopathy: assessing vascular risk in heart failure. (external link)
• Dickstein, Kenneth (2002). In the treatment of heart failure, faster may not always be better. (external link)
• Dickstein, Kenneth (2001). What should be the focus in the management of patients with heart failure? The importance of peripheral vision. (external link)
• Bonarjee, V.; Dickstein, Kenneth (2001). Management of patients with heart failure; are internists as good as cardiologists?. (external link)
• Dickstein, Kenneth (2001). ACE inhibitors in heart failure: are they irreplaceable?. (external link)
• Dickstein, Kenneth (2000). Effects of exercise training on maximal and submaximal endurance capacity in men with congestive heart failure. (external link)

Article in business/trade/industry journal

• Holm, Torbjørn; Færestrand, Svein; Larsen, Alf Inge et al. (2014). Kardial resynkroniseringsterapi ved hjertesvikt – norske retningslinjer.. (external link)

Academic lecture

• Orn, S; Manhenke, C; Ueland, Thor et al. (2008). C-reactive protein, infarct size, microvascular obstruction and left ventricular remodeling following acute myocardial infarction. (external link)
• Morken, Ingvild Margreta; Nordstokke, Ove; Berg, Leonora Hofker et al. (2005). Living with an implantable cardioverter defibrillator: A qualitative study from one Norwegian centre. (external link)
• Dickstein, Kenneth (2002). Comparison of the Effects of Losartan and Captopril on Mortality and Morbidity in patients following Acute Myocardial Infarction: The OPTIMAAL Trial. (external link)
• Dickstein, Kenneth (2002). Outpatient heart failure management programs – 4 models New markers of heart failure Determinants of long-term prognosis in heart failure Emerging therapies for heart failure. (external link)
• Dickstein, Kenneth (2002). Clinical implications of losartan in the OPTIMAAL study. (external link)
• Dickstein, Kenneth (2002). Modern Aspects of Heart Failure Management. Recent Acheivements and Future Directions. (external link)
• Dickstein, Kenneth (2002). Results of recent trials in patients with heart failure following myocardial infarction. (external link)
• Dickstein, Kenneth (2002). Angiotensin II antagonists; are they established therapy in heart failure?. (external link)
• Dickstein, Kenneth (2002). The role of angiotensin II antagonists in heart failure and following myocardial infarction. (external link)
• Dickstein, Kenneth (2002). Beta-blockers should be withdrawn in decompensated heart failure patients. (external link)
• Dickstein, Kenneth (2002). State of the art management of myocardial infarction. (external link)
• Dickstein, Kenneth (2002). ARBs are as good as ACE inhibitors. (external link)
• Dickstein, Kenneth (2002). Controlling the course of disease in the post-myocardial infarction patient: the OPTIMAAL trial. (external link)
• Larsen, A.; Lindal, S.; Aukrust, Pål et al. (2001). Effect of exercise training on muscle fibre characteristics in patients with heart failure. (external link)
• Hall, Christian; Langvik, T. A.; Aarsland, Torbjørn et al. (1996). N-terminal probrain natriuretic peptide - a new marker of cardiac function and prognosis. (external link)

Doctoral dissertation

• Larsen, Alf Inge; Dickstein, Kenneth (2004). Exercise training in congestive heart failure: evaluation of test protocols and effect on neurohormones, cytokines, heart rate variability and skeletal muscle histology. (external link)
• Dickstein, Kenneth (1991). Cardiopulmonary exercise testing after myocardial infarction: Evaluation of the methodology and its use in assessing the effect of pharmacologic intervention on functional capacity. (dr.med.). (external link)

Compendium

• Dickstein, Kenneth (2004). How and when to use angiotensin-receptor-blockers in heart failure: some theory evidence and practical guidelines. (external link)

Popular scientific article

• Dickstein, Kenneth; Snapinn, Steven M. (2003). How should we analyse hospitalisation data in clinical trials?. (external link)
• Dickstein, Kenneth (2003). What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?. (external link)

See a complete overview of publications in Cristin.